Medistim ASA (STO:MEDIO)

Market Cap	3.84B
Revenue (ttm)	576.25M
Net Income (ttm)	117.25M
Shares Out	n/a
EPS (ttm)	6.40
PE Ratio	32.79
Forward PE	31.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11
Average Volume	375
Open	231.00
Previous Close	231.00
Day's Range	231.00 - 231.00
52-Week Range	131.00 - 240.00
Beta	n/a
RSI	63.78
Earnings Date	Aug 20, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK